Membrane interaction of islet amyloid polypeptide

被引:146
作者
Jayasinghe, Sajith A.
Langen, Ralf
机构
[1] Univ So Calif, Zilkha Neurogenet Inst, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA
[2] Calif State Univ, Dept Chem & Biochem, San Marcos, CA 92096 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2007年 / 1768卷 / 08期
关键词
islet amyloid polypeptide; IAPP; membranes; aggregation; membrane damage;
D O I
10.1016/j.bbamem.2007.01.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increasing evidence suggests that the misfolding and deposition of IAPP plays an important role in the pathogenesis of type 11, or non-insulin-dependent diabetes mellitus (T2DM). Membranes have been implicated in IAPP-dependent toxicity in several ways: Lipid membranes have been shown to promote the misfolding and aggregation of IAPP. Thus, potentially toxic forms of IAPP can be generated when IAPP interacts with cellular membranes. In addition, membranes have been implicated as the target of IAPP toxicity. IAPP has been shown to disrupt membrane integrity and to permeabilize membranes. Since disruption of cellular membranes is highly toxic, such a mechanism has been suggested to explain the observed IAPP toxicity. Here, we review IAPP-membrane interaction in the context of (1) catalyzing IAPP misfolding and (2) being a potential origin of IAPP toxicity. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:2002 / 2009
页数:8
相关论文
共 93 条
[1]  
AMELO U, 1997, ENDOCRINOLOGY, V138, P4081
[2]   Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes [J].
Anguiano, M ;
Nowak, RJ ;
Lansbury, PT .
BIOCHEMISTRY, 2002, 41 (38) :11338-11343
[3]   GIANT MULTILEVEL CATION CHANNELS FORMED BY ALZHEIMER-DISEASE AMYLOID BETA-PROTEIN [A-BETA-P-(1-40)] IN BILAYER-MEMBRANES [J].
ARISPE, N ;
POLLARD, HB ;
ROJAS, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) :10573-10577
[4]   Neutron diffraction reveals sequence-specific membrane insertion of pre-fibrillar islet amyloid polypeptide and inhibition by rifampicin [J].
Balali-Mood, K ;
Ashley, RH ;
Hauss, T ;
Bradshaw, JP .
FEBS LETTERS, 2005, 579 (05) :1143-1148
[5]   Atherothrombosis, inflammation, and diabetes [J].
Biondi-Zoccai, GGL ;
Abbate, A ;
Liuzzo, G ;
Biasucci, LM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (07) :1071-1077
[6]   Two types of Alzheimer's β-amyloid (1-40) peptide membrane interactions:: Aggregation preventing transmembrane anchoring Versus accelerated surface fibril formation [J].
Bokvist, M ;
Lindström, F ;
Watts, A ;
Gröbner, G .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 335 (04) :1039-1049
[7]   SOLUTION STRUCTURE OF HUMAN CALCITONIN GENE-RELATED PEPTIDE BY H-1-NMR AND DISTANCE GEOMETRY WITH RESTRAINED MOLECULAR-DYNAMICS [J].
BREEZE, AL ;
HARVEY, TS ;
BAZZO, R ;
CAMPBELL, ID .
BIOCHEMISTRY, 1991, 30 (02) :575-582
[8]   Increased β-cell apoptosis prevents adaptive increase in β-cell mass in mouse model of type 2 diabetes -: Evidence for role of islet amyloid formation rather than direct action of amyloid [J].
Butler, AE ;
Janson, J ;
Soeller, WC ;
Butler, PC .
DIABETES, 2003, 52 (09) :2304-2314
[9]   Diabetes due to a progressive defect in β-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat) -: A new model for type 2 diabetes [J].
Butler, AE ;
Jang, J ;
Gurlo, T ;
Carty, MD ;
Soeller, WC ;
Butler, PC .
DIABETES, 2004, 53 (06) :1509-1516
[10]   EFFECTS OF MEAL INGESTION ON PLASMA AMYLIN CONCENTRATION IN NIDDM AND NONDIABETIC HUMANS [J].
BUTLER, PC ;
CHOU, J ;
CARTER, WB ;
WANG, YN ;
BU, BH ;
CHANG, D ;
CHANG, JK ;
RIZZA, RA .
DIABETES, 1990, 39 (06) :752-756